Insulin aspart, recombinant Subcutaneous and Spiriva
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Spiriva and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: tiotropium
Brand name: Spiriva Handihaler, Spiriva Respimat, Spiriva, Spiriva Respimat 30 Dose, Spiriva Respimat 14 Dose, Spiriva Respimat 28 ACT, Spiriva Respimat 60 ACT, Spiriva Respimat 10 ACT
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Spiriva Handihaler
- Insulin aspart, recombinant Subcutaneous-Spiriva Respimat
- Insulin aspart, recombinant Subcutaneous-Spironolactone
- Insulin aspart, recombinant Subcutaneous-Spironolactone and hydrochlorothiazide
- Insulin aspart, recombinant Subcutaneous-Spironolactone Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Spironolactone Tablets
- Spiriva-Insulin degludec
- Spiriva-Insulin Degludec (U-100) Prefilled Pens
- Spiriva-Insulin Degludec (U-100) Vials
- Spiriva-Insulin Degludec (U-200) Prefilled Pens
- Spiriva-Insulin degludec and liraglutide
- Spiriva-Insulin degludec and liraglutide Subcutaneous